|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2006-5-18
|
|
pubmed:abstractText |
To examine whether carbogen and nicotinamide increases 5-fluorouracil (5-FU) delivery to colorectal cancer metastases.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:AboagyeEric OEO,
pubmed-author:GuptaNishiN,
pubmed-author:HoskinPeter JPJ,
pubmed-author:JonesTerryT,
pubmed-author:KötzBarbaraB,
pubmed-author:OsmanSafiyeS,
pubmed-author:PhillipsRobertR,
pubmed-author:PricePatricia MPM,
pubmed-author:SaleemAzeemA,
pubmed-author:VernonClareC,
pubmed-author:WasanHarpreetH
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3115-23
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16707610-Administration, Inhalation,
pubmed-meshheading:16707610-Administration, Oral,
pubmed-meshheading:16707610-Aged,
pubmed-meshheading:16707610-Antimetabolites, Antineoplastic,
pubmed-meshheading:16707610-Carbon Dioxide,
pubmed-meshheading:16707610-Colorectal Neoplasms,
pubmed-meshheading:16707610-Drug Interactions,
pubmed-meshheading:16707610-Female,
pubmed-meshheading:16707610-Fluorouracil,
pubmed-meshheading:16707610-Humans,
pubmed-meshheading:16707610-Liver Neoplasms,
pubmed-meshheading:16707610-Male,
pubmed-meshheading:16707610-Middle Aged,
pubmed-meshheading:16707610-Niacinamide,
pubmed-meshheading:16707610-Oxygen,
pubmed-meshheading:16707610-Radiation-Sensitizing Agents,
pubmed-meshheading:16707610-Regional Blood Flow,
pubmed-meshheading:16707610-Tissue Distribution,
pubmed-meshheading:16707610-Vitamin B Complex
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients.
|
|
pubmed:affiliation |
Cancer Research UK PET Oncology Group and Hammersmith Imanet, Hammersmith Hospital NHS Trust, London, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
